Everhart Financial Group, Inc.
Position in CRL — Charles River Laboratories International, Inc.
CIK 1852858
Dublin, OH
Position in CRL
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$651,794
+$150,854 QoQ
Shares Held
2,874
-1.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#273
of 564 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Everhart Financial Group, Inc. holds $3,732,179 across 6 Diagnostics & Research names. CRL ranks #3 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
1,939 | $1,020,767 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,924 | $964,616 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
This page
|
2,874 | $651,794 | |
| 4 | A |
Agilent Technologies, Inc.
|
3,706 | $492,267 | |
| 5 | DHR |
Danaher Corp /De/
|
1,829 | $348,387 | |
| 6 | NTRA |
Natera, Inc.
|
937 | $254,348 |
All Filings in CRL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $651,794 | 2,874 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $500,940 | 2,904 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $525,430 | 2,634 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $298,838 | 1,910 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||